Author:
Ockerman Kyle M,Furnas Heather J,Sheer Amy,Sorice-Virk Sarah
Publisher
Oxford University Press (OUP)
Reference19 articles.
1. Public interest in the off-label use of glucagon-like peptide 1 agonists (ozempic) for cosmetic weight loss: a google trends analysis;Han;Aesthet Surg J,2023
2. User's guide to mechanism of action and clinical use of GLP-1 receptor agonists;Shaefer;Postgrad Med,2015
3. What to know about Zepbound, Eli Lilly’s new weight loss drug;Lovelace
4. The Truth About Compounded GLP-1s That Doctors Need to Know;Einav
5. Compounded (And Counterfeit) Semaglutide. Science;Lowe